Keywords: CEST / APT / NOE, CEST & MT, Glioblastoma, Cancer stem cells, Label-free CEST
Motivation: Non-invasive grading of glioblastoma (GBM) aggressiveness is critical for choosing a proper treatment paradigm
Goal(s): To develop a label-free MRI technique that can probe the presence of cancer stem cells (CSCs) in GBM.
Approach: To detect high mannose N-linked glycans overexpressed on mesenchymal CSCs with mannose-weighted (MANw) CEST MRI.
Results: MANw CEST MRI was able to produce a distinct signal for highly aggressive GBM tumor spheres but not for low aggressive ones, which corresponded to the histoptahological presence or absence of mannose expression.
Impact: We present a simple, non-invasive diagnostic approach for assessment of glioblastoma aggressiveness, which can be immediately implemented as an add-on to current MRI protocols.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords